Fumiaki Shono
- Molecular Biology
- Pharmacology top 10%
- Pharmacology top 5%
- Physiology
- Health, Toxicology and Mutagenesis top 10%
- Co-authors
- Hiroshi YamazakiKazushige YokotaMasato KitajimaMakiko ShimizuNorie MurayamaKohji NishimuraMitsuo JisakaTsutomu Nagaya
- Topics
- Inflammatory mediators and NSAID effects (10 papers)Peroxisome Proliferator-Activated Receptors (9 papers)Adipose Tissue and Metabolism (9 papers)
- Cited by
- PharmacologyBiochemistry
- Partner nations
- Japan
In The Last Decade
Fumiaki Shono
51 papers receiving 636 citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 226
- Pharmacology 149
- Pharmacology 118
- Physiology 117
- Health, Toxicology and Mutagenesis 95
Countries citing papers authored by Fumiaki Shono
This map shows the geographic impact of Fumiaki Shono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiaki Shono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiaki Shono more than expected).
Fields of papers citing papers by Fumiaki Shono
This network shows the impact of papers produced by Fumiaki Shono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiaki Shono. The network helps show where Fumiaki Shono may publish in the future.
Co-authorship network of co-authors of Fumiaki Shono
This figure shows the co-authorship network connecting the top 25 collaborators of Fumiaki Shono. A scholar is included among the top collaborators of Fumiaki Shono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiaki Shono. Fumiaki Shono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 26 | |
| 3 | 29 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | 6 | |
| 7 | 14 | |
| 8 | 3 | |
| 9 | 8 | |
| 10 | 11 | |
| 11 | 26 | |
| 12 | 9 | |
| 13 | 34 | |
| 14 | 27 | |
| 15 | 22 | |
| 16 | 2 | |
| 17 | 6 | |
| 18 | 3 | |
| 19 | 50 | |
| 20 | 4 |
About Fumiaki Shono
Fumiaki Shono is a scholar working on Pharmacology, Cancer Research and Pharmacology, having authored 54 papers that have together received 657 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Adipose Tissue and Metabolism (9 papers). The work is most often cited by research in Pharmacology (118 citations), Biochemistry (65 citations) and Pharmacology (149 citations). Fumiaki Shono has collaborated with scholars based in Japan. Frequent co-authors include Hiroshi Yamazaki, Kazushige Yokota, Masato Kitajima, Makiko Shimizu, Norie Murayama, Kohji Nishimura, Mitsuo Jisaka, Tsutomu Nagaya, Kimito Funatsu and Shozo Yamamoto. Their work appears in journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Chemosphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.